Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment

Archives of Dermatology

Volumn 141, Issue 1, 2005, Pages 43-46

  Carroll, Christie L ^a   Clarke, Jan ^b   Camacho, Fabian ^a   Balkrishnan, Rajesh ^c   Feldman, Steven R ^a,d  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALICYLIC ACID; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG PENETRATION; ERYTHEMA; FEMALE; GEL; HUMAN; MALE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THICKNESS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; GELS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; SALICYLIC ACID; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 12444288511     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.1.43     Document Type: Article

References (11)

1. Lebwohl M, Ali S. Treatment of psoriasis, II: systemic therapies. J Am Acad Dermatol. 2001;45:649-661.
2. Lebwohl M, Ali S. Treatment of psoriasis, I: topical therapy and phototherapy. J Am Acad Dermatol. 2001;45:487-498.
3. European FK 506 Multicentre Psoriasis Study Group. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. Arch Dermatol. 1996;132:419-423.
4. Zonneveld IM, Rubins A, Jablonska S, et al. Topical tacrolimus is not effective in chronic plaque psoriasis: a pilot study [published correction appears in Arch Dermatol. 1998;134:1386]. Arch Dermatol. 1998;134:1101-1102.
5. Zonneveld IM, Rubins A, JablonskaS, et al. Topical tacrolimus is not effective in chronic plaque psoriasis: a pilot study [published correction appears in Arch Dermatol. 1998;134:1386]. Arch Dermatol. 1998;134:1101-1102.
6. Remitz A, Reitamo S, Erkko P, Granlund H, Lauerma AI. Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol. 1999;141:103-107.
7. Freeman AK, Linowski GJ, Brady C, et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol. 2003; 48:564-568.
8. Lebwohl M. The role of salicylic acid in the treatment of psoriasis. Int J Dermatol. 1999;38:16-24.
9. Ruzicka T, Bieber T, Schopf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis: European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med. 1997;337:816-821.
10. Palier A, Eichenfield LF, Leung DY, Stewart D, Appell M. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2001;44(suppl):S47-S57.
11. Koo J, Cuffie CA, Tanner DJ, et al. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study. Clin Ther. 1998;20:283-291.